Hepatocellular Carcinoma Risk in Chronic Hepatitis B Virus–Infected Compensated Cirrhosis Patients With Low Viral Load Dong Hyun Sinn,1 Junggyu Lee,1 Juna Goo,2 Kyunga Kim,2 Geum-Youn Gwak,1 Yong-Han Paik,1 Moon Seok Choi,1 Joon Hyeok Lee,1 Kwang Cheol Koh,1 Byung Chul Yoo,1 and Seung Woon Paik1 Controversy exists about whether antiviral therapy (AVT) should be recommended for compensated cirrhosis patients with chronic hepatitis B virus (HBV) infection and detectable, but low, serum HBV-DNA levels. A retrospective cohort of 385 treatmentna€ıve, HBV-related compensated cirrhosis patients (mean age: 51.1 6 9.7 years; 66% male) with low HBV-DNA levels (

Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load.

Controversy exists about whether antiviral therapy (AVT) should be recommended for compensated cirrhosis patients with chronic hepatitis B virus (HBV)...
548KB Sizes 0 Downloads 11 Views